Dextrose Injection Market, By Product Type (5% Dextrose Injection, 10% Dextrose Injection, 50% Dextrose Injection, 70% Dextrose Injection, and Others), By Application (First-aid Treatment, Sports, Trophotherapy, and Others), By Distribution Channel (Hospi

Dextrose Injection Market, By Product Type (5% Dextrose Injection, 10% Dextrose Injection, 50% Dextrose Injection, 70% Dextrose Injection, and Others), By Application (First-aid Treatment, Sports, Trophotherapy, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Dextrose injection contain source of water and calories, and is capable of inducing diuresis depending on the clinical condition of the patient. Dextrose injections are sterile, non-pyrogenic, and does not contain bacteriostatic or antimicrobial agents. It is intended for intravenous administration. This intravenous solution is indicated for use in adults and pediatric patients as sources of calories and water for hydration. Dosage of dextrose injection is dependent upon the age, weight, and clinical condition of the patient as well as laboratory determinations.
Market Dynamics
Increasing launches and approval of novel products, increasing adoption of inorganic growth strategies such as collaboration and acquisition by key players operating in the market and rising demand for dextrose for first-aid treatment as instant nutrition therapy in critical care are expected to drive the growth of global dextrose injection market over the forecast period. For instance, in July 2015, B. Braun Medical Inc. received the U.S. Food and Drug Administration approval for 70% Dextrose for Injection in a 2L flexible container.
Key features of the study:
This report provides in-depth analysis of the global dextrose injection market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global dextrose injection market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Pfizer Inc., Amphastar Pharmaceuticals Inc., Shangai Haixin group Co. Ltd., Seqirus GmbH, Baxter International Inc., Shandong Qidu Pharmaceutical, Sanctus drugs and pharmaceuticals Pvt., Hospira Inc., B Braun Medical Ltd., Aurobindo Pharmaceuticals Ltd., and SteriMAx Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global dextrose injection market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global dextrose injection market
Detailed Segmentation:
Global Dextrose Injection Market, By Product Type:
5% Dextrose Injection
10% Dextrose Injection
50% Dextrose Injection
70% Dextrose Injection
Others
Global Dextrose Injection Market, By Application:
First-aid Treatment
Sports
Trophotherapy
Others
Global Dextrose Injection Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Dextrose Injection Market, By Region:
North America
By Product Type:
5% Dextrose Injection
10% Dextrose Injection
50% Dextrose Injection
70% Dextrose Injection
Others
By Application:
First-aid Treatment
Sports
Trophotherapy
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
U.S.
Canada
Latin America
By Product Type:
5% Dextrose Injection
10% Dextrose Injection
50% Dextrose Injection
70% Dextrose Injection
Others
By Application:
First-aid Treatment
Sports
Trophotherapy
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Product Type:
5% Dextrose Injection
10% Dextrose Injection
50% Dextrose Injection
70% Dextrose Injection
Others
By Application:
First-aid Treatment
Sports
Trophotherapy
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Product Type:
5% Dextrose Injection
10% Dextrose Injection
50% Dextrose Injection
70% Dextrose Injection
Others
By Application:
First-aid Treatment
Sports
Trophotherapy
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Product Type:
5% Dextrose Injection
10% Dextrose Injection
50% Dextrose Injection
70% Dextrose Injection
Others
By Application:
First-aid Treatment
Sports
Trophotherapy
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product Type:
5% Dextrose Injection
10% Dextrose Injection
50% Dextrose Injection
70% Dextrose Injection
Others
By Application:
First-aid Treatment
Sports
Trophotherapy
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Pfizer Inc. *
Company Overview
Material Portfolio
Financial Performance
Key Highlights
Market Strategies
Amphastar Pharmaceuticals Inc.
Shangai Haixin group Co. Ltd.
Seqirus GmbH
Baxter International Inc.
Shandong Qidu Pharmaceutical
Sanctus drugs and pharmaceuticals Pvt.
Hospira Inc.
B Braun Medical Ltd.
Aurobindo Pharmaceuticals Ltd.
SteriMAx Inc.
“*” marked represents similar segmentation in other categories in the respective section.